Philips Respironics today announced the Pico nasal mask is now available in the United States for the treatment of obstructive sleep apnea (OSA). Designed to maximize comfort and effectiveness, Pico is a small and light CPAP mask. The mask was recently displayed at Medtrade Spring.
The Philips Pico CPAP mask makes minimal contact with the face while still providing a tight seal. Pico improves comfort and enables better compliance, fitting more than 98% of patients, according to data from external and internal testing on file with Philips Respironics.
“As we strive to innovate new products that fit the needs of our customer base, we’re committed to producing masks that are not just effective, but also comfortable,” says Mark D’Angelo, sleep business leader of Philips, in a release. “Pico is a smart product addition for DME providers looking to offer a CPAP mask to new and existing sleep apnea patients who want minimal disruptions to their lifestyle.”
Pico is the latest addition to Philips’ portfolio of advanced mask designs, resupply solutions, and innovative technologies designed to help DME providers meet the needs of their customers as efficiently as possible. As part of “The ANSWER,” Philips is working alongside care teams, partnering to develop OSA solutions that create healthier patients and healthier business practices in a changing healthcare environment.
